Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brecher

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 6, 2007
Update on multi-center clinical trials in the United StatesAraba Afenyi-Annan, Mark E Brecher, Nicholas Bandarenko
Transfusion|June 1, 1990
Posttransfusion purpura: the therapeutic value of PlA1-negative plateletsM E Brecher, S B Moore, L Letendre
Transfusion|April 29, 1999
The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modelingM E Brecher, L T Goodnough, T Monk
Lancet (London, England)|January 18, 2003
Transfusion medicine: looking to the futureLawrence T Goodnough, Aryeh Shander, Mark E Brecher
Transfusion|September 13, 2006
Life, death, and the risk of transfusion: a university hospital experienceShauna N Hay, Lori Scanga, Mark E Brecher
Transfusion|January 14, 1998
Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yieldsN Bandarenko, L C Sims, M E Brecher
Journal of Clinical Apheresis|May 20, 1998
Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpuraJ A Cohen, M E Brecher, N Bandarenko
Transfusion|June 20, 1998
Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infectionA J Creager, M E Brecher, N Bandarenko
Transfusion|June 20, 1998
Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurementL T Goodnough, T G Monk, M E Brecher
Transfusion|April 29, 1999
Optimal platelet dosingM E Brecher, E G Hom, J K Hersh
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 6, 2007
Update on multi-center clinical trials in the United StatesAraba Afenyi-Annan, Mark E Brecher, Nicholas Bandarenko
Transfusion|June 1, 1990
Posttransfusion purpura: the therapeutic value of PlA1-negative plateletsM E Brecher, S B Moore, L Letendre
Transfusion|April 29, 1999
The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modelingM E Brecher, L T Goodnough, T Monk
Lancet (London, England)|January 18, 2003
Transfusion medicine: looking to the futureLawrence T Goodnough, Aryeh Shander, Mark E Brecher
Transfusion|September 13, 2006
Life, death, and the risk of transfusion: a university hospital experienceShauna N Hay, Lori Scanga, Mark E Brecher
Transfusion|January 14, 1998
Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yieldsN Bandarenko, L C Sims, M E Brecher
Journal of Clinical Apheresis|May 20, 1998
Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpuraJ A Cohen, M E Brecher, N Bandarenko
Transfusion|June 20, 1998
Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infectionA J Creager, M E Brecher, N Bandarenko
Transfusion|June 20, 1998
Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurementL T Goodnough, T G Monk, M E Brecher
Transfusion|April 29, 1999
Optimal platelet dosingM E Brecher, E G Hom, J K Hersh
Pageof 16